Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
Sign Up to like & getrecommendations! Published in 2020 at "Oncology"
DOI: 10.1159/000509387
Abstract: Background: Although a strong antitumor effect of lenvatinib (LEN) has been noted for patients with unresectable hepatocellular carcinoma (HCC), there are still no reports on the prognosis for patients with disease progression after first-line LEN… read more here.
Keywords: post progression; line; first line; line len ... See more keywords